About Us

Megan Buresh, MD

Candidate for Region V Director

Biography and Statement

buresh-asam-election-2020

1. What are your greatest contributions to ASAM and the field of addiction medicine?

As secretary of Maryland-DC chapter, I have led efforts to increase member engagement, with focus on engaging trainees and younger members.

As founding chair of the Addiction Consult Special Interest group, I have led efforts help ASAM members integrate addiction treatment into inpatient settings and share resources across practice settings.

As general internist and addiction medicine specialist, I have developed new ways to integrate addiction treatment into general medical setttings (including development of Johns Hopkins Bayview inpatient addiction consult service) and led clinical protocols for mobile buprenorphine clinic for justice involved individuals in Baltimore City.

2. How would your election benefit ASAM and the field of addiction medicine?

As regional director, I would build on lessons learned as MD-DC Chapter Secretary to help increase member recruitment to region chapters and recruitment of trainees and young physicians to the field of addiction medicine.

From my experience implementing addiction treatment in variety of settings (inpatient, outpatient, criminal justice and community-based), I would work to expand my region's chapters to be source of technical support to increase addiction treatment in their regions and aid workforce expansion.

Biographical Sketch

Dr. Megan Buresh is an Assistant Professor of Medicine in the Division of Addiction Medicine at the Johns Hopkins University School of Medicine with a joint appointment in epidemiology at Johns Hopkins School of Public Health. She received a Bachelor of Arts in Biochemical Sciences from Harvard University (magna cum laude with highest honors in field), completed medical school at Johns Hopkins University School of Medicine and residency at Brigham and Women’s Hospital.

She is medical director of the Johns Hopkins Bayview Inpatient Addiction Consult Service. She also provides integrated buprenorphine treatment as part of her outpatient primary care practice and is the lead physician for the BHLI Project Connections to Re-Entry (PCARE) program, a low threshold buprenorphine clinic located outside the Baltimore City Detention Center. She is currently leading a pilot to initiate opioid agonist therapies into post-acute care. Her research interests include public health and addiction, developing and evaluating models to expand office-based opioid treatment, and improving linkages between clinical addiction treatment and community organizations. She is currently the Secretary for the Maryland-DC Chapter of ASAM and Chair of the Addiction Consult Special Interest Group.